Program Schedule

Sunday, November 10, 2002
8:00 am-9:30 am Registration Open/Continental Breakfast
9:00 am-9:05 am Announcements
9:05 am-11:45 am Joint Session: New Therapies/Novel Agents
Albert A. Deisseroth, MD, PhD
Sidney Kimmel Cancer CenterMario Sznol, MD
Vion Pharmaceuticals
9:05 am-9:35 am Vector Targeting of Cancer Cells
Albert B. Deisseroth, MD, PhD
Sidney Kimmel Cancer Center
9:35 am-10:05 am Strategies to Improve T-Cell Migrations to Tumor
Patrick Hwu, MD
National Cancer Institute, NIH
10:05 am-10:35 am Immunocytokines: Versatile Molecules for Biotherapy of Malignancies
Ralph A. Reisfeld, PhD
The Scripps Research Institute
10:35 am-10:50 am Refereshment Break
10:50 am-11:15 am TRAIL R1 and R2 mAb, A Human Agonistic Monoclonal Antibody Displays in Vitro and in Vivo Activity on Human Tumor Cells
Robin C. Humphreys, PhD
Human Genome Sciences
11:15 am-11:30 am Vaccination of Reconstituted Lymphopenic Hosts Facilitates Priming of Tumor-Specific CD4+ T Cells with Therapeutic Efficacy
Christian Poehlein, MD
Earle A. Chiles Research Institute
11:30 am-11:45 am Development of a Fever-Like Heat Treatment as an Adjuvant to Cancer Immunotherapies
Michele T. Pritchard
Roswell Park Cancer Institute
11:45 am Meeting Adjourns